Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19870 studies found for:    "Vascular Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
"Vascular Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Center for the Study of Vascular Disease in Hispanic and Native Americans
Condition: Vascular Disease
Intervention:
2 Completed Beijing Vascular Disease Patients Evaluation STudy
Condition: Vascular Disease
Intervention: Other: Questionnaires and follow-up
3 Completed Efficacy of Patient Centred Information for Vascular Disease
Condition: Vascular Disease
Interventions: Other: Verbal and written information;   Other: Verbal and electronic information
4 Completed Open Label Clinical Study to Assess the Clinical Safety of a New Compression Device in Subjects With Peripheral Arterial Vascular Disease
Condition: Peripheral Arterial Vascular Disease
Intervention: Procedure: A new treatment approach is to have an effective working pressure combined with a low resting pressure.
5 Completed Screening DIVA - Diffuse Vascular Disease
Condition: Peripheral Vascular Diseases
Intervention:
6 Completed Stem Cell Injection for Peripheral Vascular Disease
Condition: Peripheral Vascular Disease
Intervention: Biological: Stem Cell Transplantation
7 Not yet recruiting Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients
Condition: Peripheral Vascular Disease Patient
Intervention: Device: Multi-spectral Imaging Device (MSID)
8 Completed
Has Results
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients
Condition: Vascular Diseases
Interventions: Drug: Gadobutrol (Gadavist, Gadovist, BAY86-4875);   Drug: Gadopentate dimeglumine (Magnevist, BAY86-4882)
9 Completed Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
Conditions: Vascular Disease;   Vascular Disease Risk
Intervention:
10 Unknown  Noninvasive Predictors of Transplant Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
11 Completed Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular Disease
Conditions: Hemodialysis Patients;   Peripheral Vascular Disease
Intervention: Drug: Cilostazol
12 Withdrawn Noninvasive Evaluation of Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention:
13 Terminated Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients
Condition: Cardiac Allograft Vasculopathy
Intervention: Drug: Sirolimus
14 Unknown  Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Intervention: Drug: Intravitreal Bevacizumab
15 Active, not recruiting Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
Condition: Cardiac Allograft Vasculopathy
Intervention:
16 Completed Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs
Condition: Polypoidal Choroidal Vasculopathy
Intervention:
17 Completed Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular Disease
Condition: PERIPHERAL VASCULAR DISEASE
Interventions: Procedure: Conventional angioplasty balloon;   Procedure: cryoplasty balloon
18 Completed Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
Conditions: Diabetes Mellitus;   Peripheral Vascular Disease
Interventions: Drug: Testosterone;   Drug: 0.9% saline
19 Active, not recruiting Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling
Conditions: Vasculopathy;   Allograft
Intervention: Procedure: Dobutamine stress echocardiography, coronarography, brachial arterial echography
20 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.